Most read article(s)

Open Access
Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
Zhijin Chen, Akshay Jain, Hao Liu, Zhen Zhao and Kun Cheng

Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 695-702; DOI: https://doi.org/10.1124/jpet.118.256156
Open Access
Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor
Tetsuya Taniguchi, Naoki Ashizawa, Koji Matsumoto, Ryo Saito, Keisuke Motoki, Miku Sakai, Noriko Chikamatsu, Chiharu Hagihara, Masamichi Hashiba and Takashi Iwanaga

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 162-170; DOI: https://doi.org/10.1124/jpet.119.259341
Open Access
Targeting Enteropeptidase with Reversible Covalent Inhibitors To Achieve Metabolic Benefits
Weimei Sun, Xuqing Zhang, Maxwell D. Cummings, Kamal Albarazanji, Jiejun Wu, Mina Wang, Richard Alexander, Bin Zhu, YueMei Zhang, James Leonard, James Lanter and James Lenhard

Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 510-521; DOI: https://doi.org/10.1124/jpet.120.000219
Open Access
Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore

Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
You have access
Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features
Ryuichi Ohgaki, Ling Wei, Kazunori Yamada, Taiki Hara, Chiaki Kuriyama, Suguru Okuda, Kiichiro Ueta, Masaharu Shiotani, Shushi Nagamori and Yoshikatsu Kanai

Journal of Pharmacology and Experimental Therapeutics July 2016, 358 (1) 94-102; DOI: https://doi.org/10.1124/jpet.116.232025
You have access
Microneedle Coating Methods: A Review with a Perspective
Rohan S.J. Ingrole and Harvinder Singh Gill

Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 555-569; DOI: https://doi.org/10.1124/jpet.119.258707
Open Access
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor
Michelle G. Baladi, Michael J. Forster, Michael B. Gatch, Richard B. Mailman, Danielle L. Hyman, Lawrence P. Carter and Aaron Janowsky

Journal of Pharmacology and Experimental Therapeutics August 2018, 366 (2) 367-376; DOI: https://doi.org/10.1124/jpet.118.248120
You have access
Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis
Randy Torralva and Aaron Janowsky

Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 453-475; DOI: https://doi.org/10.1124/jpet.119.258566
You have access
Role of GILZ in the Kidney and the Cardiovascular System: Relevance to Cardiorenal Complications of COVID-19
Mahmood S. Mozaffari

Journal of Pharmacology and Experimental Therapeutics December 2020, 375 (3) 398-405; DOI: https://doi.org/10.1124/jpet.120.000243
Open Access
Mechanistic Analysis of an Extracellular Signal–Regulated Kinase 2–Interacting Compound that Inhibits Mutant BRAF-Expressing Melanoma Cells by Inducing Oxidative Stress
Ramon Martinez, Weiliang Huang, Ramin Samadani, Bryan Mackowiak, Garrick Centola, Lijia Chen, Ivie L. Conlon, Kellie Hom, Maureen A. Kane, Steven Fletcher and Paul Shapiro

Journal of Pharmacology and Experimental Therapeutics January 2021, 376 (1) 84-97; DOI: https://doi.org/10.1124/jpet.120.000266

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals